IFNB1 and neoplasm: In humans, IFN-β modulates the profiles of tumor-associated macrophages (TAMs) from M2 to M1 phenotypes, leading to a decreased proportion of Tregs among tumor infiltrating leukocytes (TILs) at the tumor site [10].